These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38321884)

  • 1. Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing.
    Wang X; He T; Chen Z; Chen J; Luo Y; Lin D; Li X; Liu D
    Lab Chip; 2024 Mar; 24(6):1702-1714. PubMed ID: 38321884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gel-Free Single-Cell Culture Arrays on a Microfluidic Chip for Highly Efficient Expansion and Recovery of Colon Cancer Stem Cells.
    Liu Y; Chen X; Chen J; Luo Y; Chen Z; Lin D; Zhang J; Liu D
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3623-3632. PubMed ID: 35786837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forming Single-Cell-Derived Colon Cancer Organoid Arrays on a Microfluidic Chip for High Throughput Tumor Heterogeneity Analysis.
    Chen Z; Chen J; Lin D; Kang H; Luo Y; Wang X; Wang L; Liu D
    ACS Biomater Sci Eng; 2024 Aug; 10(8):5265-5273. PubMed ID: 39087916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Cell Culture Model Utilization in Renal Carcinoma Cancer Stem Cell Research.
    Maliszewska-Olejniczak K; Brodaczewska KK; Bielecka ZF; Czarnecka AM
    Methods Mol Biol; 2018; 1817():47-66. PubMed ID: 29959702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microgel Single-Cell Culture Arrays on a Microfluidic Chip for Selective Expansion and Recovery of Colorectal Cancer Stem Cells.
    Lin D; Chen X; Liu Y; Lin Z; Luo Y; Fu M; Yang N; Liu D; Cao J
    Anal Chem; 2021 Sep; 93(37):12628-12638. PubMed ID: 34495647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single-Cell Clone-Forming Inhibition Assay.
    Lin D; Li P; Feng J; Lin Z; Chen X; Yang N; Wang L; Liu D
    Small; 2020 Mar; 16(9):e1901001. PubMed ID: 30998296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer.
    Czarnecka AM; Solarek W; Kornakiewicz A; Szczylik C
    Oncol Rep; 2016 Mar; 35(3):1433-42. PubMed ID: 26708631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
    Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
    Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Single-Cell Expansion on a Microfluidic Chip for Studying Heterogeneity of Glioma Stem Cells.
    Li P; Qin Z; Zhong Y; Kang H; Zhang Z; Hu Y; Wen L; Wang L
    Anal Chem; 2022 Feb; 94(7):3245-3253. PubMed ID: 35148070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine regulates cell growth and survival in renal cell cancer.
    Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
    Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.
    Sakai I; Miyake H; Fujisawa M
    BJU Int; 2013 Jul; 112(2):E211-20. PubMed ID: 23305097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
    Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
    Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
    Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L
    Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.